Novel Cinnamaldehyde Hydrazones: Design, In Silico Evaluation, Synthesis, and Cytotoxic Activity
Molecules · 17.05.2026 · 31 (10) · 1701
DOI: 10.3390/molecules31101701 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 17.05.2026. Verfasst von Boryana Nikolova-Mladenova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Acrolein, Hydrazones, Antineoplastic Agents, Drug Design. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Science Council (SMN) at MU-Sofia.
Abstract (Originalsprache)
(1)
Background
Cinnamaldehyde exhibits a broad spectrum of biological activities, and its α,β-unsaturated aldehyde scaffold serves as a versatile platform for the design of hydrazone derivatives with improved pharmacological properties. (2)
Methods
In this study, eight cinnamaldehyde-based hydrazones were synthesized via a one-step condensation reaction between cinnamaldehyde and para-substituted acylhydrazides. Prior to synthesis, an in silico assessment of physicochemical, pharmacokinetic, ADME (absorption, distribution, metabolism, elimination), lead-likeness, and drug-likeness properties was conducted using SwissADME, ACD/Labs v. 9.10, and MDL QSAR v2.2.0.0.446 software. Structural characterization by IR, 1H NMR, 13C NMR, and HR ESI–MS confirmed successful formation of the hydrazone linkage. Cytotoxic activity was evaluated using the MTT assay against selected cancer cell lines. (3)
Results
All compounds exhibited favorable lead-like characteristics, including suitable molecular weight, moderate lipophilicity, and acceptable predicted ADME profiles. Biological evaluation revealed moderate, structure-dependent antiproliferative activity with clear cell line selectivity. Among the series, compound CA8 showed the most promising profile, displaying the highest cytotoxic activity against T-cell leukemia KE-37 cells (IC50 = 20.3 ± 2.8 μM), comparable to reference drug melphalan (IC50 = 21.40 ± 3.9 μM), and the highest selectivity index (≥19.7). Structure–activity analysis suggests that an amino substituent enhances both potency and selectivity. (4)
Conclusions
Overall, these findings identify cinnamaldehyde hydrazones as a promising scaffold for anticancer drug development and provide a strong basis for further structural optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria.
- Department of Pharmacology, Pharmacotherapy and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria.
- Centre of Excellence in Informatics and Information and Communication Technologies, Bulgarian Academy of Sciences, Akad. Georgi Bonchev Str., Block 2 and 25A, 1113 Sofia, Bulgaria.
ORCID-Profile: Boryana Nikolova-Mladenova, Rositsa Mihaylova, Mariyana Atanasova
Förderung
- Medical Science Council (SMN) at MU-Sofia
Zitieren
APA
Nikolova-Mladenova, B., Mihaylova, R., & Atanasova, M. (2026). Novel Cinnamaldehyde Hydrazones: Design, In Silico Evaluation, Synthesis, and Cytotoxic Activity. Molecules, 31(10), 1701. https://doi.org/10.3390/molecules31101701
Vancouver
Nikolova-Mladenova B, Mihaylova R, Atanasova M. Novel Cinnamaldehyde Hydrazones: Design, In Silico Evaluation, Synthesis, and Cytotoxic Activity. Molecules. 2026;31(10):1701. doi:10.3390/molecules31101701
BibTeX
@article{NikolovaMladenova2026,
author = {Nikolova-Mladenova, Boryana and Mihaylova, Rositsa and Atanasova, Mariyana},
title = {Novel Cinnamaldehyde Hydrazones: Design, In Silico Evaluation, Synthesis, and Cytotoxic Activity},
journal = {Molecules},
year = {2026},
volume = {31},
number = {10},
pages = {1701},
doi = {10.3390/molecules31101701}
}
EUVIMED